Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,240 | -3,240 | 4,880 | -2,100 | 660 |
| Depreciation Amortization | 1,190 | 300 | 250 | 240 | 970 |
| Other Working Capital | -1,500 | 190 | -200 | -2,490 | 1,400 |
| Other Operating Activity | -7,660 | 430 | -6,360 | 120 | -7,170 |
| Operating Cash Flow | $-10,210 | $-2,320 | $-1,430 | $-4,230 | $-4,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -390 | -50 | -110 | -70 | -660 |
| Net Acquisitions | -8,700 | 0 | 0 | 0 | -1,380 |
| Other Investing Activity | 12,240 | -6,090 | 11,540 | 4,970 | -6,230 |
| Investing Cash Flow | $3,150 | $-6,140 | $11,430 | $4,900 | $-8,270 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 9,610 | 9,150 | 430 | 200 | 13,250 |
| Financing Cash Flow | $9,610 | $9,150 | $430 | $200 | $13,250 |
| Exchange Rate Effect | 490 | 600 | 0 | 0 | 0 |
| Beginning Cash Position | 4,690 | 15,980 | 5,580 | 4,710 | 4,050 |
| End Cash Position | 7,740 | 17,270 | 16,010 | 5,580 | 4,880 |
| Net Cash Flow | $3,050 | $1,290 | $10,430 | $870 | $830 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,210 | -2,320 | -1,430 | -4,230 | -4,140 |
| Free Cash Flow | -10,210 | -2,320 | -1,430 | -4,230 | -4,140 |